Hui-Yu Chen

LinKou Chang Gung Memorial Hospital, Taiwan

Poster(s):

• (74) A Real-World Effectiveness of Second-Line Osimertinib in NSCLC Patients: A Multi-Institutions Study in Taiwan
  Saturday, August 27, 2022

  8:00 AM – 6:00 PM CEST

• (L) Comparative Cardiovascular Events Associated with Denosumab Vs. Zoledronate in The Elderly: A 5-Year Follow-Up Propensity Score Matching Cohort
  Friday, August 26, 2022

  8:00 AM – 6:00 PM CEST

• (75) Comparative Effectiveness of Regorafenib and Nivolumab as Sequential Therapies in Patients After Sorafenib Failure for Hepatocellular Carcinoma Patients: A Cohort Study in Taiwan
  Saturday, August 27, 2022

  8:00 AM – 6:00 PM CEST

• (71) Real-World Effectiveness and Safety of Ramucirumab in Hepatocellular Carcinoma Patients: A Retrospective Study in Taiwan
  Saturday, August 27, 2022

  8:00 AM – 6:00 PM CEST

• (97) Real-World Prescription Pattern Among Patients with Inflammatory Bowel Disease in Taiwan: A Multi-Institutional Electronic Medical Records Database Analysis
  Saturday, August 27, 2022

  8:00 AM – 6:00 PM CEST